Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Novo Nordisk is making a strategic push into India's weight-loss market to secure its position ahead of competition from ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

In early April, President Donald Trump gathered dozens of hard-hat-clad coal miners around him in the White House East Room.

What is the difference between prediabetes and diabetes, and which do I have? I am male, 85 years old, 170 pounds, and 6 feet ...

Despite their benefits, there are a number of things to consider before taking weight loss drugs – including possible ...

The liver is responsible for more than 500 functions in the human body, including filtering harmful substances from the blood ...

A San Antonio weight loss clinic owner is encouraging consumers of the GLP-1 drug semaglutide not to panic now that the FDA ...

"Social media will turn everyone into brain-dead zombies with a medieval-level understanding of the real world." ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...